D. C. Guven Et Al. , "The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy," Journal of Oncology Pharmacy Practice , vol.28, no.4, pp.785-793, 2022
Guven, D. C. Et Al. 2022. The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy. Journal of Oncology Pharmacy Practice , vol.28, no.4 , 785-793.
Guven, D. C., KAVGACI, G., Aktepe, O. H., Yildirim, H. C., Sahin, T. K., AKSOY, S., ... ERMAN, M.(2022). The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy. Journal of Oncology Pharmacy Practice , vol.28, no.4, 785-793.
Guven, Deniz Et Al. "The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy," Journal of Oncology Pharmacy Practice , vol.28, no.4, 785-793, 2022
Guven, Deniz C. Et Al. "The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy." Journal of Oncology Pharmacy Practice , vol.28, no.4, pp.785-793, 2022
Guven, D. C. Et Al. (2022) . "The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy." Journal of Oncology Pharmacy Practice , vol.28, no.4, pp.785-793.
@article{article, author={Deniz C Guven Et Al. }, title={The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy}, journal={Journal of Oncology Pharmacy Practice}, year=2022, pages={785-793} }